What is the typical dosing for Seroquel (quetiapine) ER?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seroquel ER Dosing

For Seroquel XR (extended-release quetiapine), initiate at 300 mg once daily on day 1, increase to 600 mg on day 2, and target 400-800 mg once daily thereafter, with dose adjustments based on clinical response and tolerability. 1, 2

Standard Dosing by Formulation

Extended-Release (XR) Formulation

  • Rapid titration schedule: 300 mg once daily on day 1, then 600 mg on day 2, with maintenance dosing of 400-800 mg once daily starting day 3 2
  • The XR formulation offers the convenience of once-daily dosing, which may improve adherence compared to immediate-release formulations 2
  • Maximum dose is 800 mg/day for schizophrenia 1

Immediate-Release (IR) Formulation

  • Standard titration for schizophrenia: Day 1: 25 mg twice daily, Day 2: 50-100 mg total (divided doses), Day 3: 200 mg total, Day 4: 300-400 mg total 1
  • Target dose range: 150-750 mg/day divided into 2-3 doses, with maximum of 750 mg/day 1, 3
  • Both twice-daily and three-times-daily dosing regimens are equally effective at 450 mg/day total 4

Indication-Specific Dosing

Schizophrenia (Adults)

  • Target dose: 400-800 mg/day for maintenance 1
  • Effective doses typically ≥250 mg/day, with maximum efficacy at higher doses within the therapeutic range 5

Bipolar Depression

  • Administer once daily at bedtime: Day 1: 50 mg, Day 2: 100 mg, Day 3: 200 mg, Day 4: 300 mg 1
  • Target and maximum dose: 300 mg/day 1, 6

Bipolar Mania (Adults)

  • Day 1: 100 mg total (divided), Day 2: 200 mg, Day 3: 300 mg, Day 4: 400 mg 1
  • Target range: 400-800 mg/day, maximum 800 mg/day 1

Special Population Adjustments

Elderly Patients

  • Start at 50 mg/day with 50 mg/day incremental increases 1
  • Maximum dose for Alzheimer's-related behavioral disturbances: 400 mg/day total (200 mg twice daily), starting at 12.5 mg twice daily 3, 7
  • Critical warning: Do not use schizophrenia maximum doses (750-800 mg/day) in elderly patients with dementia 3
  • Monitor orthostatic hypotension vigilantly during titration 3, 7

Hepatic Impairment

  • Start at 25 mg/day with 25-50 mg/day incremental increases 1

Drug Interactions

  • With CYP3A4 inhibitors (ketoconazole, ritonavir): Reduce dose to one-sixth of original dose 1
  • With CYP3A4 inducers (phenytoin, carbamazepine): Increase dose up to 5-fold of original dose when used chronically (>7-14 days) 1

Critical Safety Monitoring

During Initial Titration

  • Monitor orthostatic vital signs, especially in elderly patients and those on CNS depressants 3, 7
  • Assess for excessive sedation, which is more prominent with quetiapine than other atypical antipsychotics 3

Discontinuation

  • Taper gradually over 10-14 days when discontinuing—avoid abrupt cessation to prevent rebound insomnia, agitation, and symptom relapse 3, 8
  • Withdrawal symptoms can occur with rapid dose decreases 3

Common Pitfalls to Avoid

  • Do not exceed 6 mg daily of risperidone when cross-titrating (note: this applies to switching scenarios, not quetiapine monotherapy) 8
  • Do not use maximum schizophrenia doses in elderly dementia patients—the ceiling is 400 mg/day, not 750-800 mg/day 3
  • Quetiapine does not cause sustained prolactin elevation, distinguishing it from many other antipsychotics 4, 5
  • The relatively short 6-hour half-life does not predict dosing frequency; twice-daily dosing is adequate for immediate-release formulations 4, 5

Reinitiation After Treatment Gap

  • If quetiapine has been discontinued for more than one week, restart using the initial titration schedule rather than resuming the previous maintenance dose 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.